1. Duomao Lin, Jun Ma*. Penehyclidine hydrochloride preconditioning provides cardioprotection in a rat model of myocardial ischemia/reperfusion injury, Plos One,2015Dec 2;10(12):e0138051.
2. Duomao Lin, Yanyan Xue, Zhaoqi Wang, Jun Ma*. Protective Effects and Mechanism of Penehyclidine Hydrochloride on Myocardial Ischemia Reperfusion Injury in rats. Journal of the American College of Cardiology,66 (16)suppl s:c43-44,2015.
3. Zhaoqi Wang#, Duomao Lin#, Liang Zhang,Wenjun Liu,Hongbao Tan, Jun Ma*. Penehyclidine hydrochloride prevents anoxia/reoxygenation injury and induces H9c2 cardiomyocyte apoptosis via a mitochondrial pathway. European Journal of Pharmacology,2017 Feb 15;vol.797:115-123. (#共一作者)
4. 林多茂,赵丽云*,马骏.妊娠合并重度特发性肺动脉高压患者行剖宫产术的麻醉处理. 中国医药,12(3):407-411,2017.
5. 谭红保,林多茂*,马骏.盐酸戊乙奎醚预先给药对大鼠心肌缺血再灌注时线粒体调控凋亡通路的影响.中华麻醉学杂志,37(10):1267-1270,2017.
6. Duomao Lin, Boqun Cui, Jiayue Ren, Jun Ma*. Regulation of VDAC1 contributes to the cardioprotective effects of penehyclidine hydrochloride during myocardial ischemia/reperfusion. Experimental Cell Research, 2018June15;vol.367:257-263.
7. 齐择优,马骏,林多茂*.加速康复外科理念指导下胃肠手术围术期舒芬太尼临床剂量的优化.中国医药,13(3):404-407,2018.
8. Lin D, Cui B, Ma J, Ren J. MiR-183-5p protects rat hearts against myocardial ischemia/reperfusion injury through targeting VDAC1. BioFactors, 2020 Jan;46(1);83–93. https://doi.org/10. 1002/biof.1571
9. JY Ren#, DM Lin#, CB Wang, YL Yang, ZQ Wang, BQ Cui, J Ma*. Postconditioning protection against myocardiocyte anoxia/reoxygenation injury from penehyclidine hydrochloride. Drug Design, Development and Therapy, 2019,13:3977–3988. (#共一作者)
10. 林多茂,卢家凯,张冬妮,马骏*.心尖入路经导管主动脉瓣植入术的麻醉管理. 中国微创外科杂志,20(6):489-493,2020.
11. 林多茂,齐择优,马骏*.危机管理模拟教学法在麻醉科住院医师规培教学中的应用.医学教育管理, 6(s1):40-42,2020.
12. 林多茂, 张冬妮,卢家凯,马骏*.监测麻醉在经股动脉主动脉瓣植入术中的应用.心肺血管病杂志, 40(3):258-260+277,2021.
13. 陈方园,林多茂*.剖宫产术中应用舒芬太尼对卡前列素所诱发不良反应的影响.中国医药,2023,18(01):91-94.
14. Lin D*, Cui B, Qi Z, Liu W, Zhang G. A New Aspect of Penehyclidine Hydrochloride in Alleviating Myocardial Ischemia-Reperfusion Injury: Ferroptosis. J Cardiovasc Transl Res. 2023 Dec;16(6):1373-1382. doi: 10.1007/s12265-023-10420-7.
15. Cui B, Qi Z, Liu W, Zhang G, Lin D*. ZBP1-mediated PANoptosis: A possible novel mechanism underlying the therapeutic effects of penehyclidine hydrochloride on myocardial ischemia-reperfusion injury. Int Immunopharmacol. 2024 Aug 20;137: 112373. doi: 10.1016/j.intimp.2024.112373.
16. 张官正,齐择优,李兆阳,张芷伊,沈筱苒,林多茂*.氯胺酮及其对映体用于治疗术后抑郁的研究进展.中国医药,2025,20(03):476-480.
17. 张官正,齐择优,裴丽坚,卜德亮,李兆阳,沈晓苒,张芷伊,王坚刚,李扬,林多茂*.体外循环下心脏瓣膜术后出血与术前相关因素分析.心肺血管病杂志,2025,44(05): 495-499.
18. Gao J, Li L, Zhai S, Dong Y, Zhang Z, Lin D*, Ma J*. Exercise training for myocardial ischemia reperfusion injury: Mechanism and clinical practice (Review). Int J Mol Med. 2025 Nov;56(5):191. doi: 10.3892/ijmm.2025.5632. Epub 2025 Sep 12. PMID: 40937559; PMCID: PMC12440276.
19. 沈筱苒,齐择优,张官正,李兆阳,张芷伊,林多茂*.布比卡因脂质体用于心脏手术后镇痛的研究进展.临床麻醉学杂志,2026,42(01):71-75.